TD Asset Management’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Hold |
42,420
| – | – | ﹤0.01% | 1134 |
|
|
2025
Q1 | $504K | Buy |
42,420
+3,186
| +8% | +$37.9K | ﹤0.01% | 1146 |
|
|
2024
Q4 | $739K | Sell |
39,234
-1,200
| -3% | -$22.6K | ﹤0.01% | 1141 |
|
|
2024
Q3 | $932K | Buy |
40,434
+12,000
| +42% | +$277K | ﹤0.01% | 1200 |
|
|
2024
Q2 | $593K | Buy |
+28,434
| New | +$593K | ﹤0.01% | 1248 |
|
|
2023
Q1 | – | Sell |
-43,259
| Closed | -$475K | – | 1455 |
|
|
2022
Q4 | $475K | Hold |
43,259
| – | – | ﹤0.01% | 1295 |
|
|
2022
Q3 | $558K | Hold |
43,259
| – | – | ﹤0.01% | 1277 |
|
|
2022
Q2 | $548K | Sell |
43,259
-19,872
| -31% | -$252K | ﹤0.01% | 1275 |
|
|
2022
Q1 | $884K | Sell |
63,131
-26,606
| -30% | -$373K | ﹤0.01% | 1252 |
|
|
2021
Q4 | $2.6M | Buy |
89,737
+20,775
| +30% | +$601K | ﹤0.01% | 1072 |
|
|
2021
Q3 | $2.07M | Hold |
68,962
| – | – | ﹤0.01% | 1074 |
|
|
2021
Q2 | $2.12M | Buy |
68,962
+620
| +0.9% | +$19.1K | ﹤0.01% | 1074 |
|
|
2021
Q1 | $2.13M | Buy |
68,342
+30,398
| +80% | +$945K | ﹤0.01% | 1087 |
|
|
2020
Q4 | $1.25M | Hold |
37,944
| – | – | ﹤0.01% | 1133 |
|
|
2020
Q3 | $1.33M | Buy |
+37,944
| New | +$1.33M | ﹤0.01% | 1021 |
|